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Incubation of isolated hepatocytes containing normal Ca2+ levels with angiotensin II, vasopressin or
A23187 caused significant inhibition of the CAMP response to glucagon. Angiotensin II also inhibited 
CAMP accumulation i duced by either glucagon or epinephrine inCa2+ -depleted hepatocytes. When sub- 
maximal doses of hormone were employed such that cell CAMP was elevated only 3-4-fold (-2 pmol 
cAMP/mg wet wt cells) inhibition by angiotensin II was correlated with a decrease in phosphorylase 
activation. The data demonstrate hat inhibition of hepatic CAMP accumulation results in reduced 
metabolic responses to glucagon and epinephrine and do not support the contention that the hepatic 
actions of glucagon are independent of CAMP. 
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1. INTRODUCTION 2. EXPERIMENTAL 
Epinephrine, angiotensin II and vasopressin can 
inhibit glucagon induced CAMP accumulation in 
liver [l-4]. However, controversy has arisen con- 
cerning the ability of these hormones to inhibit the 
physiological responses induced by glucagon. Us- 
ing rat hepatocytes containing normal Ca2+ levels, 
we reported that epinephrine, angiotensin II and 
vasopressin were able to inhibit glucagon- 
stimulated conversion of [i4C]lactate to 
[14C]glucose [2]. However, in Ca2+-depleted 
hepatocytes physiological responses induced by 
glucagon were unaffected by angiotensin II despite 
a marked reduction in CAMP levels [4]. This led to 
the proposition that, in hepatocytes, ‘the effect of 
glucagon on CAMP levels can be dissociated from 
its metabolic effects’ [4]. Here, we investigate the 
apparent discrepancy between these conclusions. 
We demonstrate that in Ca2+-depleted hepatocytes 
angiotensin II is able to inhibit both glucagon- and 
epinephrine-stimulated CAMP accumulation and 
phosphorylase activation if submaximal doses of 
agonists are used and CAMP levels are 
< 2 pmol/mg wet wt cells. 
Parenchymal cells from the livers of fed male 
Sprague-Dawley rats (body wt 200-220 g) were 
isolated and incubated as in [5]. Calcium-depleted 
hepatocytes were prepared by washing and in- 
cubating the cells in Krebs-Henseleit bicarbonate 
buffer containing 1 mM EGTA without added 
Ca2+ [6]. Methods for the measurement of 
phosphorylase a and CAMP levels have been detail- 
ed in [5-71. 
(-)Epinephrine bitartrate, angiotensin II and 
arginine-vasopressin were from Sigma. Glucagon 
and A23187 were gifts from Lilly (IN). cu-D- 
[U-i4C]Glucose- 1 -P was from New England 
Nuclear (MA). 
3. RESULTS 
The data in fig.1 show the effect of 10e8 M 
angiotensin II on the dose response for elevation of 
CAMP and activation of phosphorylase by 
glucagon, in Ca2+-depleted hepatocytes. Under 
these conditions angiotensin II itself does not ac- 
tivate phosphorylase (fig.lA). Glucagon at 5 x 
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Fig.1. Effect of angiotensin II on CAMP accumulation 
(A) and phosphorylase activation (B) induced by 
glucagon in Ca*+-depleted hepatocytes. Isolated 
hepatocytes were incubated with increasing doses of 
glucagon in the presence or absence of angiotensin II 
(Angio II, lo-’ M). After 2 min, samples were removed 
for determination of CAMP and phosphorylase II. 
Values are means f SEM of triplicate incubations 
each assayed in duplicate from an experiment 
representative of 2. 
lo-” M raised CAMP to -1.8 pmol/mg wet wt of 
cells (fig.lA) and produced maximum activation 
of phosphorylase (fig. 1B). Angiotensin II was able 
to inhibit CAMP accumulation and phosphorylase 
activation at all concentrations of glucagon used. 
A similar inhibition of CAMP accumulation and 
phosphorylase activation was observed when 
( -)epinephrine was used as the stimulus in 
Ca2+-depleted hepatocytes (fig.2A,B). In the 
Ca2+-depleted situation, epinephrine acts via both 
,&- and cq-adrenergic receptors to elevate CAMP 
F-5,81. 
In hepatocytes containing normal levels of Ca2+, 
angiotensin II, vasopressin and A23 187 inhibited 
the ability of both glucagon and exogenously add- 
ed CAMP to stimulate synthesis of [14C]glucose 
from [14C]lactate [2]. Hepatocyte CAMP levels 
were measured in some, but not all, of those ex- 
periments. The data in table 1 show that angioten- 
sin II, vasopressin and A23187 were all able to in- 
hibit hepatic CAMP accumulation elicited by 
glucagon. However, CAMP levels under these con- 
ditions were > 2 pmol/mg wet wt of cells, which 
is enough to stimulate gluconeogenesis maximally 
[5]. Thus, other factors besides CAMP must have 
been responsible for the inhibition of 
gluconeogenesis observed in these studies [2]. 
4. DISCUSSION 
Controversy has arisen concerning the ability of 
the hormone angiotensin II to inhibit physiological 
responses induced by glucagon in hepatocytes. 
Cardenas-Tanus et al. have claimed that angioten- 
sin II is able to inhibit glucagon induced CAMP ac- 
cumulation in hepatocytes without modulating 
physiological responses to this hormone [4]. 
However, these workers used high concentrations 
of glucagon which are known to induce CAMP 
levels in liver far in excess of those needed to max- 
imally activate physiological processes [9]. As we 
demonstrate here, when low doses of glucagon are 
employed such that CAMP levels are 
~2.0 pmol/mg cells, the inhibitory effect of 
angiotensin II on CAMP shows a close correlation 
with the extent of phosphorylase activation. In- 
spection of the data in [4] reveals that, in their ex- 
periments, hepatic CAMP was still elevated by 
6.4-fold (2.3 f 0.23 pmol/mg cells) in the presence 
of angiotensin II. As demonstrated here (fig. 1) and 
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Fig.2. Effect of angiotensin II on CAMP accumulation 
(A) and phosphorylase activation (B) induced by 
epinephrine in Ca’+-depleted hepatocytes. Isolated 
hepatocytes were incubated with increasing doses of 
epinephrine in the presence or absence of angiotensin II 
(Angio II, lo-* M). After 2 min, samples were removed 
for determination of CAMP and phosphorylase a. 
Values are means + SEM of triplicate incubations each 
assayed in duplicate from an experiment representative 
of 2. 
Table 1 
Effects of angiotensin II, vasopressin 
glucagon induced CAMP formation 
hepatocytes 
March 1983 
and A23187 on 
in Ca*+-replete 
Additions to 
incubation medium 
Cont. 
(M) 
CAMP level 
(pmol/mg 
wet wt cells) 
Saline 
Angiotensin II 
Vasopressin 
A23187 
Glucagon 
Glucagon + 
vasopressin 
Glucagon + 
angiotensin II 
Glucagon + 
A23187 
0.53 + 0.09 
10-8 0.50 * 0.03 
IO-* 0.56 + 0.01 
lo-’ 0.61 + 0.07 
1o-9 3.65 + 0.39 
1o-9 
10-s 
2.77 k 0.24a 
1o-9 
10-* 
2.54 + 0.14b 
1O-9 
1O-5 
1.97 f 0.17’ 
ap < 0.05 
bp < 0.01 
’ p < 0.005 vs glucagon alone 
Isolated hepatocytes were incubated as shown for 1 min 
when samples were removed for CAMP determination. 
Values are means + SEM of triplicate incubations each 
assayed in duplicate, from an experiment representative 
of 2 
in [5], this level of CAMP is sufficient to cause 
maximal activation of phosphorylase and 
gluconeogenesis. We contend, therefore, that valid 
support for the suggestion that the hepatic actions 
of glucagon are independent of CAMP is not pro- 
vided in [4]. 
The ability of angiotensin II to lower CAMP in 
Ca2+-depleted hepatocytes is probably due to an 
inhibition of adenylate cyclase [1,3]. This is sup- 
ported by the observation that CAMP increases in- 
duced by either glucagon or epinephrine are in- 
hibited by angiotensin II (fig. 1,2). Since the former 
two hormones have independent receptors 
mediating adenylate cyclase activation in liver cells 
[lo-121 it seems unlikely that angiotensin II would 
exert its influence directly at the receptor level. In- 
deed in juvenile hepatocytes, where epinephrine- 
induced CAMP elevation is mediated entirely by 
Pz-adrenergic receptors [8] (rather than by both,&- 
and al-receptors as in the Ca’+-depleted situation 
[6,8]) angiotensin II also inhibits the response (not 
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shown). In addition, angiotensin II was unable to (4) Since CAMP levels are still more than suffi- 
inhibit phosphorylase activation elicited by ex- cient to m~im~ly stimulate glu~oneogenesis 
ogenously added CAMP (not shown), suggesting under these conditions it is proposed that 
that its action must be at the level of CAMP changes in Ca2+ flux are, at least partially, 
generation. responsible for the inhibition observed [2]. 
In Ca”-replete hepatocytes, angiotensin II, 
vasopressin, A23187 and epinephrine can all in- 
hibit gluconeogenesis from [U-i4C]lactate [2]. 
However, cAMP levels were not measured under 
all conditions in that study. Under similar condi- 
tions the glucagon-induced elevation of hepatic 
CAMP was markedly inhibited by each of these 
agents (table I), although CAMP levels still exceed- 
ed 2 pmol/mg wet wt cells, a value which would be 
sufficient to cause maximal stimulation of 
gluconeogenesis [5]. Furthermore, these agents 
were also able to inhibit the gluconeogenic effects 
of exogenous CAMP, a response which would not 
be expected if they were acting only to inhibit 
adenylate cyclase. It was proposed that changes in 
Ca2+ redistribution might account for the inhibi- 
tion, since it is known that Ca2+ can regulate the 
gluconeogenic pathway [13]. When a CAMP 
stimulus (e.g., glucagon) is combined with a Ca2+ 
mobilising hormone (e.g., epinephrine, angioten- 
sin II and vasopressin) net cellular Ca2+ influx is 
the result [14]. This can be accounted for by a net 
increase in mitochondrial CaZ” content [ 141 and we 
propose that this phenomenon may then be 
responsible for the observed inhibition of 
gluconeogenesis [2]. Since [4] was done with 
Ca’*-depleted hepatocytes, this would account for 
the failure to observe inhibition of gluconeogenesis 
by angiotensin II when CAMP levels were still 
elevated. 
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